CY1107932T1 - Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων - Google Patents
Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκωνInfo
- Publication number
- CY1107932T1 CY1107932T1 CY20071100938T CY071100938T CY1107932T1 CY 1107932 T1 CY1107932 T1 CY 1107932T1 CY 20071100938 T CY20071100938 T CY 20071100938T CY 071100938 T CY071100938 T CY 071100938T CY 1107932 T1 CY1107932 T1 CY 1107932T1
- Authority
- CY
- Cyprus
- Prior art keywords
- interlevkin
- suspensions
- transfer suspension
- tumor transfer
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13104799A IL131047A0 (en) | 1999-07-22 | 1999-07-22 | Use of il-18 inhibitors |
| EP00944201A EP1206274B1 (en) | 1999-07-22 | 2000-07-17 | Use of interleukin-18 inhibitors to inhibit tumor metastasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107932T1 true CY1107932T1 (el) | 2013-09-04 |
Family
ID=11073044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100938T CY1107932T1 (el) | 1999-07-22 | 2007-07-13 | Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7741276B2 (https=) |
| EP (1) | EP1206274B1 (https=) |
| JP (1) | JP4827352B2 (https=) |
| KR (1) | KR100682219B1 (https=) |
| CN (1) | CN1173736C (https=) |
| AR (1) | AR024907A1 (https=) |
| AT (1) | ATE363288T1 (https=) |
| AU (1) | AU782478B2 (https=) |
| BG (1) | BG65800B1 (https=) |
| BR (1) | BR0012675A (https=) |
| CA (1) | CA2380216C (https=) |
| CY (1) | CY1107932T1 (https=) |
| CZ (1) | CZ302114B6 (https=) |
| DE (2) | DE60035049T2 (https=) |
| DK (1) | DK1206274T3 (https=) |
| EA (1) | EA005419B1 (https=) |
| EE (1) | EE04838B1 (https=) |
| ES (1) | ES2186596T3 (https=) |
| HK (1) | HK1048248B (https=) |
| HU (1) | HU228780B1 (https=) |
| IL (2) | IL131047A0 (https=) |
| MX (1) | MXPA02000838A (https=) |
| NO (1) | NO329827B1 (https=) |
| NZ (1) | NZ516535A (https=) |
| PL (1) | PL202477B1 (https=) |
| PT (1) | PT1206274E (https=) |
| SK (1) | SK287522B6 (https=) |
| TR (1) | TR200200169T2 (https=) |
| UA (1) | UA73745C2 (https=) |
| WO (1) | WO2001007480A2 (https=) |
| ZA (1) | ZA200200390B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2399148A1 (en) | 2000-02-10 | 2001-08-16 | Abbott Laboratories | Antibodies that bind human interleukin-18 and methods of making and using |
| JP2004528010A (ja) | 2000-10-11 | 2004-09-16 | バイロン・セラピューティックス・インコーポレーテッド | 免疫モジュレーションのための核酸およびポリペプチド |
| US7718368B2 (en) | 2000-12-04 | 2010-05-18 | Viron Therapeutics Inc. | Immunomodulatory protein and useful embodiments thereof |
| EP1425028B1 (en) * | 2001-05-16 | 2009-12-16 | Yeda Research And Development Co. Ltd. | Use of il-18 inhibitors for the treatement or prevention of sepsis |
| RU2225720C1 (ru) * | 2002-08-12 | 2004-03-20 | Научно-исследовательский институт онкологии Томского научного центра СО РАМН | Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана |
| AU2003299919B2 (en) * | 2002-10-08 | 2009-08-06 | Ares Trading S.A. | The use of cytokine able to bind IL-18BP and of inhibiting the activity of a second cytokine |
| US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
| AU2006254103B2 (en) | 2005-06-03 | 2012-09-06 | Ares Trading S.A. | Production of recombinant IL-18 binding protein |
| AU2006256763B2 (en) | 2005-06-10 | 2012-08-02 | Ares Trading S.A. | Process for the purification of IL-18 binding protein |
| CL2008002153A1 (es) | 2007-07-24 | 2009-06-05 | Amgen Inc | Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r. |
| US9812033B2 (en) * | 2013-03-06 | 2017-11-07 | Venkatesh R. Chari | Tactile graphic display |
| WO2023178192A1 (en) | 2022-03-15 | 2023-09-21 | Compugen Ltd. | Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer |
| KR20250133728A (ko) | 2023-01-06 | 2025-09-08 | 라센 테라퓨틱스, 인코포레이티드 | 항-il-18bp 항체 |
| TW202515608A (zh) | 2023-06-26 | 2025-04-16 | 以色列商坎布根有限公司 | Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0178958B1 (ko) * | 1992-09-02 | 1999-03-20 | 데이비드 제이.엑커 | 세포 흡착의 올리고누클레오티드 조절 |
| US7141393B2 (en) * | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| SK122199A3 (en) * | 1997-03-18 | 2000-12-11 | Basf Ag | Methods and compositions for modulating responsiveness to corticosteroids |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
-
1999
- 1999-07-22 IL IL13104799A patent/IL131047A0/xx unknown
-
2000
- 2000-07-17 EA EA200200189A patent/EA005419B1/ru not_active IP Right Cessation
- 2000-07-17 PT PT00944201T patent/PT1206274E/pt unknown
- 2000-07-17 PL PL353732A patent/PL202477B1/pl unknown
- 2000-07-17 AT AT00944201T patent/ATE363288T1/de active
- 2000-07-17 HU HU0202107A patent/HU228780B1/hu unknown
- 2000-07-17 AU AU58432/00A patent/AU782478B2/en not_active Expired
- 2000-07-17 DK DK00944201T patent/DK1206274T3/da active
- 2000-07-17 TR TR2002/00169T patent/TR200200169T2/ unknown
- 2000-07-17 ES ES00944201T patent/ES2186596T3/es not_active Expired - Lifetime
- 2000-07-17 CZ CZ20020195A patent/CZ302114B6/cs not_active IP Right Cessation
- 2000-07-17 MX MXPA02000838A patent/MXPA02000838A/es active IP Right Grant
- 2000-07-17 DE DE60035049T patent/DE60035049T2/de not_active Expired - Lifetime
- 2000-07-17 CA CA2380216A patent/CA2380216C/en not_active Expired - Lifetime
- 2000-07-17 DE DE1206274T patent/DE1206274T1/de active Pending
- 2000-07-17 KR KR1020027000682A patent/KR100682219B1/ko not_active Expired - Lifetime
- 2000-07-17 BR BR0012675-6A patent/BR0012675A/pt not_active IP Right Cessation
- 2000-07-17 EP EP00944201A patent/EP1206274B1/en not_active Expired - Lifetime
- 2000-07-17 EE EEP200200032A patent/EE04838B1/xx unknown
- 2000-07-17 JP JP2001512563A patent/JP4827352B2/ja not_active Expired - Lifetime
- 2000-07-17 WO PCT/IL2000/000419 patent/WO2001007480A2/en not_active Ceased
- 2000-07-17 SK SK88-2002A patent/SK287522B6/sk not_active IP Right Cessation
- 2000-07-17 CN CNB008106894A patent/CN1173736C/zh not_active Expired - Lifetime
- 2000-07-17 HK HK02108154.3A patent/HK1048248B/zh not_active IP Right Cessation
- 2000-07-17 UA UA2002021472A patent/UA73745C2/uk unknown
- 2000-07-17 NZ NZ516535A patent/NZ516535A/en not_active IP Right Cessation
- 2000-07-21 AR ARP000103786A patent/AR024907A1/es unknown
-
2002
- 2002-01-11 NO NO20020153A patent/NO329827B1/no not_active IP Right Cessation
- 2002-01-16 ZA ZA200200390A patent/ZA200200390B/xx unknown
- 2002-01-16 BG BG106311A patent/BG65800B1/bg unknown
- 2002-01-17 IL IL147675A patent/IL147675A/en unknown
-
2007
- 2007-07-06 US US11/825,548 patent/US7741276B2/en not_active Expired - Fee Related
- 2007-07-13 CY CY20071100938T patent/CY1107932T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107932T1 (el) | Χρηση αναστολεων ιντερλευκινης-18 για αναστολη μεταστασης ογκων | |
| YU84303A (sh) | Postupak dobijanja cetp inhibitora | |
| HRP20070196T3 (hr) | Postupak za pročišćavanje il-18 vezivnog proteina | |
| CY1115124T1 (el) | Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης | |
| SV2003001103A (es) | Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester pc10894 | |
| SE0000540D0 (sv) | New compounds | |
| DE69928697D1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
| DE60143520D1 (de) | Inhibitoren der histon-deacetylase | |
| PT1315694E (pt) | Inibidores da adesao celular mediada por alfa 4 | |
| ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
| ATE390629T1 (de) | Mikrophysiomessgerät | |
| IS6039A (is) | Tálmi við súlfamatóhýdroxamsýrumálmprótínkljúfi | |
| AU2003211093A8 (en) | Inhibitors of rgs proteins | |
| ITMI20021620A1 (it) | Composto ad ativita' antitumorale | |
| DE60229420D1 (de) | Neue metallproteinaseinhibitoren | |
| DE60335497D1 (de) | Ergillus-phytasen | |
| BR9710919A (pt) | Proteina purificada sr-p70 | |
| HRP20050382A2 (en) | Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases | |
| DE60220192D1 (de) | Defragmentierung von uebertragungssequenzen | |
| AU2003251681A1 (en) | Ghrelin binding nucleic acids | |
| CY1111289T1 (el) | Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη | |
| IL154974A0 (en) | Inhibition of the growth factor dependency of tumor cells | |
| DE50311665D1 (de) | Guanidinophenylalanin-verbindungen als urokinase-inhibitoren | |
| NO20024679D0 (no) | Krystallinsk farmasöytikum | |
| DK1556412T3 (da) | IL-18BP promotor, fremstilling og anvendelse deraf |